InsidersTradesSigma
Follow the 삼천당제약 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 삼천당제약 has recorded 2 public disclosures. Market capitalisation: €3,698.4bn. The latest transaction was filed on 6 April 2026 (Mixed). Among the most active insiders: 전인석. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Samchundang Pharmaceutical es una empresa farmacéutica surcoreana centrada en el desarrollo y la fabricación de medicamentos. Cotiza en el mercado XKRX.